Nicholas Investment Partners’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-43,094
Closed -$3.58M 332
2014
Q1
$3.58M Buy
+43,094
New +$3.58M 0.3% 106